
Please try another search
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company also develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Tanya N. Lewis | 52 | 2023 | Director |
Vincenzo Berghella | - | 2024 | Member of Preeclampsia Scientific Advisory Board |
Dietrich John Pauls | 54 | 2005 | President, CEO & Director |
James T. Parsons | 60 | 2015 | Independent Chairman |
R. Michael Giuffre | 69 | 2010 | Independent Director |
John Volpi | - | - | Member of Stroke Clinical Advisory Board |
Philip Bath | - | 2023 | Member of Stroke Advisory Board |
Scott Eric Kasner | - | - | Member of Stroke Clinical Advisory Board |
Charles Pauling Semba | 64 | 2021 | Independent Director |
Richard Edward Kuntz | 68 | 2023 | Independent Director |
Stephen Tong | - | 2024 | Member of Preeclampsia Scientific Advisory Board |
Michael D. Hill | - | 2024 | Member of the Stroke Advisory Board |
Bob Silver | - | 2024 | Member of Preeclampsia Scientific Advisory Board |
Cathy Cluver | - | 2024 | Member of Preeclampsia Scientific Advisory Board |
Daniel J. O’Connor | 60 | 2025 | Independent Director |
Susan Walker | - | 2024 | Member of Preeclampsia Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review